Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Roche has agreed to acquire PathAI, a Boston-based digital ...
MARION, Ill. (WSIL) — CorePath Laboratories has launched an integrated digital pathology network in collaboration with Deaconess Illinois Medical Center, marking a significant step forward in ...
The UAB Department of Pathology launched its digital pathology initiative in November 2024. Today, the effort is only gaining momentum. The program’s implementation is scheduled to be completed by ...
Kameda Medical Center, a private medical group in Japan, has started implementing a digital pathology system as part of its transition to a new enterprise pathology platform. According to a press ...
In this interview, industry expert Dr. Raj Singh discusses the PathoVerse, a pioneering global digital ecosystem designed to transform pathology through connectivity, AI integration, and collaborative ...
In the most traditional definition of return-on-investment, Sam Terese, former CEO and president of Alverno Laboratories, would say that his company isn’t experiencing a strict apples-to-apples ...
This Special Article provides a comprehensive review and expert commentary on the prospective clinical implementation of artificial intelligence (AI) in the detection of prostate cancer from digital ...
Reviving the tradition of unveiling game-changing announcements at the J.P. Morgan Healthcare Conference, Nvidia made a major announcement to kick off the 2025 conference, a significant departure from ...
1. Mayo Clinic has digitized its extensive archive of pathology slides and continues to scan slides from current patients. The digital platform now includes 20 million slide images linked to 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results